Skip to main content
. 2022 Jan 12;126(6):937–947. doi: 10.1038/s41416-021-01621-5

Fig. 4. Validation of IL-6 using qRT-PCR of LCM samples and ELISA of serum samples.

Fig. 4

a PCR validation of IL-6 TF in cSI vs cSII/III patients in the TF and b TC. c IL-6 ELISA comparing cSI and cSII/III patients showed significantly elevated serum IL-6 levels in cSI patients. p < 0.05 and ∗∗p < 0.01.